Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> hearts show decreased cardiomyocyte cross-sectional area. حسب Jennifer L. Carleton (22208916)

الموضوعات:

Detection of changes in <i>vascular endothelial growth factor</i> (<i>VEGF</i>) and <i>RP11-502I4.3</i> expression levels. حسب Lan Zeng (638254)

الموضوعات:

Number of finishers by age group for women and men with the overall race times for each age group (HH:MM:SS). حسب Beat Knechtle (5504402)

الموضوعات:

The performance difference between the sexes (in percent) across age groups for split disciplines and overall race times. حسب Beat Knechtle (5504402)

الموضوعات:

Participants by event status and sex. حسب Beat Knechtle (5504402)

الموضوعات:

S1 Data - حسب Beat Knechtle (5504402)

الموضوعات:

Sex difference in swimming by split disciplines by the type of swim, bike, and run course. حسب Beat Knechtle (5504402)

الموضوعات:

Average split and overall race times (HH:MM:SS). حسب Beat Knechtle (5504402)

الموضوعات:

Split and overall race times for women and by age group. حسب Beat Knechtle (5504402)

الموضوعات:

Trends of average and best race times for IRONMAN^® age group triathletes. حسب Beat Knechtle (5504402)

الموضوعات:

S2 Data - حسب Beat Knechtle (5504402)

الموضوعات:

Number of finishers by sex and men-to-women ratio over the years between 2002 and 2022. حسب Beat Knechtle (5504402)

الموضوعات:

Split and overall IRONMAN^® race times histograms for women and men. حسب Beat Knechtle (5504402)

الموضوعات:

Men-to-women ratio across age groups. حسب Beat Knechtle (5504402)

الموضوعات:

Trend of the sex difference across years in overall race time. حسب Beat Knechtle (5504402)

الموضوعات:

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. حسب Matthew Drill (22258391)

"…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …"

Estimated average absolute and relative changes from the no-policy counterfactual by phase and high-in status. حسب Lindsey Smith Taillie (3159258)

الموضوعات:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and beverage group. حسب Lindsey Smith Taillie (3159258)

الموضوعات:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and food group. حسب Lindsey Smith Taillie (3159258)

الموضوعات:

The changing trends of the main differential metabolites in the WKY, SHR and Model groups. حسب Xiao Zhang (152326)

الموضوعات: